“…16 With regard to ICPMs, Guyot et al reported no infections in 229 patients who underwent placement of Camino (Integra LifeSciences) intraparenchymal ICP monitors; 27 in addition, rates of infection with concurrent placement of EVDs and ICPMs seem to be similar to those of EVD placement alone. 2,5 To date, the majority of studies reporting VAI rates have been in TBI-predominant patient populations; however, in a large retrospective analysis of 116,813 patients with aneurysmal SAH, 32.9% were managed with EVDs, with a mean annual rate of infection of 7.3%. 48 In a similar retrospective analysis of the Nationwide Inpatient Sample of 34,238 patients with spontaneous intracranial hemorrhage, a subset of patients with VAIs had an overall significant increase in the rate of inpatient mortality, length of stay, and cost of care.…”